Skip to main content
Log in

PPSV23 vaccination cost effective in elderly in China

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Zhao D, et al. Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine : 9 Nov 2016. Available from: URL: http://doi.org/10.1016/j.vaccine.2016.11.003

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PPSV23 vaccination cost effective in elderly in China. PharmacoEcon Outcomes News 767, 26 (2016). https://doi.org/10.1007/s40274-016-3586-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3586-z

Navigation